Adverse events · heavy menstrual bleeding
LNG‐IUS probably leads to lower adverse events compared with any other medical treatment (moderate certainty).
1 finding from 1 review
Treatment withdrawal for any reason Duration of treatment (range): 12 (3 months) to 36 weeks · heavy menstrual bleeding
LNG‐IUS probably leads to lower withdrawal from treatment for any reason compared with any other medical treatment (moderate certainty).
1 finding from 1 review
Treatment failure · heavy menstrual bleeding
LNG‐IUS probably leads to lower treatment failure compared with any other medical treatment (moderate certainty).
1 finding from 1 review
Costs · heavy menstrual bleeding
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Bleeding · heavy menstrual bleeding
1 finding from 1 review
Satisfaction with treatment · heavy menstrual bleeding
LNG‐IUS showed no clear difference in satisfaction with treatment compared with endometrial ablation (low certainty).
1 finding from 1 review
Regression of EH; by length of · endometrial hyperplasia
LNG‐IUS probably leads to higher regression of EH; by length of compared with non‐intrauterine progestogen (moderate certainty).
2 findings from 1 review
Hysterectomy; histologically and non‐histologically indicated · endometrial hyperplasia
LNG‐IUS may leads to lower hysterectomy; histologically and non‐histologically indicated compared with non‐intrauterine progestogen (low certainty).
1 finding from 1 review
Adverse effects associated with hormones:Bleeding/spotting Nausea Weight gain · endometrial hyperplasia
It is very uncertain whether LNG‐IUS changes adverse effects associated with hormones:Bleeding/spotting Nausea… compared with non‐intrauterine progestogen (very low certainty).
1 finding from 1 review
Adverse effects requiring withdrawal/discontinuation of study medication · endometrial hyperplasia
LNG‐IUS showed no clear difference in withdrawal secondary to adverse effects compared with non‐intrauterine progestogen (low certainty).
1 finding from 1 review
Satisfaction with treatment · endometrial hyperplasia
It is very uncertain whether LNG‐IUS changes satisfaction with treatment compared with non‐intrauterine progestogen (very low certainty).
1 finding from 1 review
Satisfaction rate: surgery versus LNG‐IUS Endometrial ablation versus LNG‐IUS At 2 years · women with heavy menstrual bleeding
Surgery showed no clear difference in satisfaction rate: surgery versus LNG‐IUS Endometrial ablation… compared with LNG‐IUS (low certainty).
1 finding from 1 review
Proportion of women with adverse events Endometrial ablation versus LNG‐IUS. At one year · women with heavy menstrual bleeding
Surgery probably leads to lower proportion of women with adverse events Endometrial ablation versus… compared with LNG‐IUS (moderate certainty).
1 finding from 1 review
Objective control of bleeding: menstrual loss under 80 ml per cycle LNG‐IUS versus hysterectomy At 1 year · women with heavy menstrual bleeding
Surgery probably leads to higher objective control of bleeding: menstrual loss under 80 ml per cycle… compared with LNG‐IUS (moderate certainty).
1 finding from 1 review
Subjective control of bleeding: PBAC no more than 75 per cycle Endometrial resection or ablation versus LNG‐IUS At 1 year · women with heavy menstrual bleeding
Surgery may leads to higher subjective control of bleeding: PBAC no more than 75 per cycle… compared with LNG‐IUS (low certainty).
1 finding from 1 review
Satisfaction rate: surgery versus LNG‐IUS Endometrial ablation versus LNG‐IUS At 1 year · women with heavy menstrual bleeding
Surgery showed no clear difference in satisfaction rate: surgery versus LNG‐IUS Endometrial ablation… compared with LNG‐IUS (low certainty).
1 finding from 1 review
Overall pain at 12 months  · Patients with symptomatic endometriosis following surgery
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Chronic pelvic pain at 12 months Â
1 finding from 1 review
Dysmenorrhoea at 12 months Â
1 finding from 1 review
Improvement of the most troublesome symptom at 12 months Â
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found